Cobalt as a Cofactor for α-Galactosaminidase-Catalyzed Cleavage of Blood Group Antigens-Reference-Cited by-同舟云学术

Cobalt as a Cofactor for α-Galactosaminidase-Catalyzed Cleavage of Blood Group Antigens

Published:2024-08-26 Issue:17 Volume:14 Page:13497-13508
ISSN:2155-5435
Container-title:ACS Catalysis
language:en
Short-container-title:ACS Catal.

Author:

Tian Yuqing¹²³,Worrall Liam J.⁴⁵,Sim Lyann¹²,Liu Feng¹,Nasseri Seyed A.¹²^ORCID,Rahfeld Peter¹²⁶,Mu Wanmeng³^ORCID,Kizhakkedathu Jayachandran N.⁷⁸^ORCID,Strynadka Natalie C. J.⁴⁵^ORCID,Withers Stephen G.¹²⁴^ORCID

Affiliation:

1. Department of Chemistry, University of British Columbia, 2036 Main Mall, Vancouver, British Columbia V6T 1Z1, Canada

2. Michael Smith Laboratories, 2185 East Mall, Vancouver, British Columbia V6T 1Z4, Canada

3. State Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi, Jiangsu 214122, People’s Republic of China

4. Department of Biochemistry and Molecular Biology, Life Sciences Institute, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada

5. Centre for Blood Research, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada

6. Avivo Biomedical Inc., Vancouver, British Columbia V6E 4E5, Canada

7. Department of Pathology and Laboratory Medicine, Centre for Blood Research, Life Sciences Institute, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada

8. School of Biomedical Engineering, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada

Funder

Canadian Institutes of Health Research

Canadian Glycomics Network

China Scholarship Council

Natural Sciences and Engineering Research Council of Canada

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acscatal.4c03643

Reference53 articles.

1. Targeting cancer glycosylation repolarizes tumor-associated macrophages allowing effective immune checkpoint blockade

2. An enzymatic pathway in the human gut microbiome that converts A to universal O type blood

3. Enzymatic conversion of human blood group A kidneys to universal blood group O

4. Ex vivo enzymatic treatment converts blood type A donor lungs into universal blood type lungs

5. Accommodation in ABO-incompatible organ transplants